Panacea Biotec

New Delhi, India
Hybrid — also manufactures internal programs
Oral Solid Dose Vaccines Sterile Injectables
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (2) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP ✓ HC GMP (4)

Quick Facts: Panacea Biotec

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
New Delhi, India
Website
Modalities
Oral Solid Dose, Vaccines, Sterile Injectables
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Panacea Biotec

Panacea Biotec makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Oral Solid Dose, Vaccines, Sterile Injectables. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.panaceabiotec.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Panacea Biotec FDA Inspection History

2023-10
2022-06
NAI VAI OAI
Date Site Type Observations Classification
2023-10-12
Panacea Biotec Pharma Limited
Malpur Company-level
Drug Quality Assurance Yes Official Action Indicated (OAI)
2022-06-08
Panacea Biotec Pharma Limited
Malpur Company-level
Drug Quality Assurance No Official Action Indicated (OAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Panacea Biotec FDA 483 Findings 9 observations · 2023-10-12 → 2023-10-12 ?

By subsystem

  • Equipment & Facilities 2 (22.2%)
  • Environmental Monitoring 2 (22.2%)
  • Documentation & Records 2 (22.2%)
  • Personnel & Training 1 (11.1%)
  • Laboratory Controls 1 (11.1%)
  • CAPA 1 (11.1%)

By severity

  • 4 — Serious: 2
  • 3 — Moderate: 2
  • 2 — Minor: 5
  • Repeat observations: 0

Most severe findings

  • Serious (4) Environmental Monitoring 2023-10-12 21 CFR 211.113(b)
    Validation lacking for sterile drug products

    "Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation of the aseptic process."

  • Serious (4) Environmental Monitoring 2023-10-12 21 CFR 211.42(c)(10)(iv)
    Environmental Monitoring System

    "Aseptic processing areas are deficient regarding the system for monitoring environmental conditions."

  • Moderate (3) Laboratory Controls 2023-10-12 21 CFR 211.160(b)
    Scientifically sound laboratory controls

    "Laboratory controls do not include the establishment of scientifically sound and appropriate specifications, standards, sampling plans and test procedures designed to assure that components, drug product containers, closures, in-process materials, labeling and drug products conform to appropriate standards of identity, strength, quality and purity."

EMA Non-Compliance Statements 1

NNGYK/11120-1/2026 — Panacea Biotec Pharma Limited, India
Issued: 2026-02-03
Source: EMA EudraGMDP · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Panacea Biotec

How many FDA inspections does Panacea Biotec have on record?
CDMO Signal tracks 2 FDA inspections for Panacea Biotec, sourced from the FDA inspection database. See the full inspection history above.
Has Panacea Biotec received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Panacea Biotec.
Does Panacea Biotec have a CDMO Signal Score?
Not yet. Panacea Biotec is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Panacea Biotec for a manufacturing program?
Use the free AI matchmaker to compare Panacea Biotec against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

BDR Pharmaceuticals
Mumbai, India
Oncology Products, Oral Solid Dose, Sterile Injectables, Small Molecule API
Cadila Pharmaceuticals (CDMO-CMO)
Ahmedabad, Gujarat, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Biologics
Medicamen Biotech
New Delhi, India
Sterile Injectables, Lyophilization, Oral Solid Dose
Torrent Pharma CDMO (formerly JB Pharma)
Ahmedabad, Gujarat, India
Finished Dosage Forms, Oral Solid Dose, Sterile Injectables, Semi-solids & Liquids, Non-sterile Liquids
Diamond Animal Health
Des Moines, Iowa, United States
Veterinary, Vaccines, Microbial Fermentation, Viral Antigens, Sterile Fill-Finish, Lyophilization, Non-sterile Liquids, Oral Solid Dose

Compare Panacea Biotec with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Panacea Biotec
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.